Literature DB >> 9517925

Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

M Gniadkowski1, I Schneider, R Jungwirth, W Hryniewicz, A Bauernfeind.   

Abstract

Twelve ceftazidime-resistant isolates of the family Enterobacteriaceae (11 Klebsiella pneumoniae isolates and 1 Escherichia coli isolate) were collected in 1995 from three Polish hospitals located in different cities. All were identified as producers of extended-spectrum beta-lactamases (ESBLs). Detailed analysis of their beta-lactamase contents revealed that six of them expressed SHV-5-like ESBLs. The remaining six were found to produce three different TEM enzymes, each characterized by a pI value of 6.0 and specified by new combinations of amino acid substitutions. The amino acid substitutions compared to the TEM-1 beta-lactamase sequence were Gly238Ser, Glu240Lys, and Thr265Met for TEM-47; Leu21Phe, Gly238Ser, Glu240Lys, and Thr265Met for TEM-48; and Leu21Phe, Gly238Ser, Glu240Lys, Thr265Met, and Ser268Gly for TEM-49. The new TEM beta-lactamases, TEM-47, TEM-48, and TEM-49, belong to a subfamily of TEM-2-related enzymes. Genes coding for TEM-47 and TEM-49 could have originated from the TEM-48-encoding sequence by various single genetic events. The new TEM derivatives probably document the already advanced microevolution of ESBLs ongoing in Polish hospitals, in a majority of which no monitoring of ESBL producers was performed before 1996.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9517925      PMCID: PMC105491     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

Review 1.  A functional classification scheme for beta-lactamases and its correlation with molecular structure.

Authors:  K Bush; G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

2.  SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.

Authors:  P A Bradford; C Urban; A Jaiswal; N Mariano; B A Rasmussen; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

Review 3.  Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.

Authors:  J R Knox
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

4.  Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genes.

Authors:  C Chanal; D Sirot; H Malaure; M C Poupart; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

5.  Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains.

Authors:  A van Belkum; J Kluytmans; W van Leeuwen; R Bax; W Quint; E Peters; A Fluit; C Vandenbroucke-Grauls; A van den Brule; H Koeleman
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit.

Authors:  R A Venezia; F J Scarano; K E Preston; L M Steele; T P Root; R Limberger; W Archinal; M A Kacica
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

7.  Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.

Authors:  A Bauernfeind; I Stemplinger; R Jungwirth; P Mangold; S Amann; E Akalin; O Anğ; C Bal; J M Casellas
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

8.  Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase.

Authors:  N J Legakis; L S Tzouvelekis; G Hatzoudis; E Tzelepi; A Gourkou; T L Pitt; A C Vatopoulos
Journal:  J Hosp Infect       Date:  1995-11       Impact factor: 3.926

9.  Effect of threonine-to-methionine substitution at position 265 on structure and function of TEM-1 beta-lactamase.

Authors:  W Huang; Q Q Le; M LaRocco; T Palzkill
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

10.  Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.

Authors:  C Cantu; W Huang; T Palzkill
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

View more
  29 in total

1.  Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland.

Authors:  Anna Baraniak; Janusz Fiett; Agnieszka Sulikowska; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

Review 2.  Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.

Authors:  P A Bradford
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

3.  TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.

Authors:  J Kamile Rasheed; Gregory J Anderson; Anne Marie Queenan; James W Biddle; Antonio Oliver; George A Jacoby; Karen Bush; Fred C Tenover
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Clonal and horizontal dissemination of Klebsiella pneumoniae expressing SHV-5 extended-spectrum beta-lactamase in a Mexican pediatric hospital.

Authors:  Guadalupe Miranda; Natividad Castro; Blanca Leaños; Adriana Valenzuela; Ulises Garza-Ramos; Teresa Rojas; Fortino Solórzano; Lilia Chihu; Jesús Silva
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

5.  Caz-hi, and extended-spectrum TEM beta-lactamase (TEM-61), is derived from Caz-lo (TEM-11) by in vivo selection.

Authors:  T De Baere; M Vaneechoutte; G Verschraegen
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

6.  Experimental evolution of gene duplicates in a bacterial plasmid model.

Authors:  Alisha K Holloway; Timothy Palzkill; James J Bull
Journal:  J Mol Evol       Date:  2007-01-08       Impact factor: 2.395

7.  A novel extended-spectrum TEM-type beta-lactamase, TEM-138, from Salmonella enterica serovar Infantis.

Authors:  Chedly Chouchani; Renaud Berlemont; Afef Masmoudi; Moreno Galleni; Jean-Marie Frere; Omrane Belhadj; Kamel Ben-Mahrez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

8.  Dissemination of CTX-M-15 beta-lactamase genes carried on Inc FI and FII plasmids among clinical isolates of Escherichia coli in a university hospital in Istanbul, Turkey.

Authors:  Nevriye Gonullu; Zerrin Aktas; Cigdem Bal Kayacan; Melek Salcioglu; Alessandra Carattoli; Dong Eun Yong; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2008-01-09       Impact factor: 5.948

9.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

10.  Molecular epidemiology of Serratia marcescens in two hospitals in Gdańsk, Poland, over a 5-year period.

Authors:  Lukasz Naumiuk; Anna Baraniak; Marek Gniadkowski; Beata Krawczyk; Bartosz Rybak; Ewa Sadowy; Alfred Samet; Józef Kur
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.